Shanghai Kinlita Chemical Past Earnings Performance
Past criteria checks 1/6
Shanghai Kinlita Chemical's earnings have been declining at an average annual rate of -35.9%, while the Chemicals industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 4.6% per year. Shanghai Kinlita Chemical's return on equity is 2.4%, and it has net margins of 2.8%.
Key information
-35.9%
Earnings growth rate
-35.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -4.6% |
| Return on equity | 2.4% |
| Net Margin | 2.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Shanghai Kinlita Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 733 | 20 | 133 | 43 |
| 31 Dec 23 | 735 | 14 | 132 | 43 |
| 30 Sep 23 | 667 | -15 | 136 | 46 |
| 30 Jun 23 | 673 | -51 | 148 | 48 |
| 31 Mar 23 | 623 | -83 | 154 | 44 |
| 01 Jan 23 | 633 | -106 | 165 | 44 |
| 30 Sep 22 | 695 | -136 | 148 | 45 |
| 30 Jun 22 | 691 | -149 | 154 | 43 |
| 31 Mar 22 | 788 | -159 | 184 | 44 |
| 01 Jan 22 | 858 | -111 | 172 | 40 |
| 30 Sep 21 | 954 | -33 | 203 | 36 |
| 30 Jun 21 | 1,028 | 58 | 205 | 32 |
| 31 Mar 21 | 1,010 | 113 | 180 | 31 |
| 31 Dec 20 | 885 | 91 | 178 | 31 |
| 30 Sep 20 | 845 | 70 | 164 | 29 |
| 30 Jun 20 | 788 | 29 | 147 | 29 |
| 31 Mar 20 | 752 | 26 | 132 | 28 |
| 31 Dec 19 | 814 | 30 | 136 | 29 |
| 30 Sep 19 | 817 | 29 | 128 | 29 |
| 30 Jun 19 | 809 | 22 | 126 | 28 |
| 31 Mar 19 | 815 | 8 | 126 | 28 |
| 31 Dec 18 | 809 | 11 | 119 | 27 |
| 30 Sep 18 | 803 | 18 | 123 | 24 |
| 30 Jun 18 | 790 | 27 | 108 | 36 |
| 31 Mar 18 | 795 | 44 | 111 | 30 |
| 31 Dec 17 | 798 | 47 | 120 | 24 |
| 30 Sep 17 | 792 | 57 | 119 | 19 |
| 30 Jun 17 | 788 | 57 | 135 | 0 |
| 31 Mar 17 | 800 | 64 | 142 | 0 |
| 31 Dec 16 | 790 | 70 | 142 | 0 |
| 30 Sep 16 | 752 | 73 | 142 | 0 |
| 30 Jun 16 | 747 | 74 | 138 | 0 |
| 31 Mar 16 | 719 | 70 | 136 | 0 |
| 31 Dec 15 | 702 | 69 | 130 | 0 |
| 30 Sep 15 | 677 | 70 | 119 | 0 |
| 30 Jun 15 | 662 | 75 | 114 | 0 |
| 31 Mar 15 | 686 | 86 | 108 | 0 |
| 31 Dec 14 | 693 | 88 | 111 | 0 |
| 30 Sep 14 | 694 | 81 | 114 | 0 |
| 30 Jun 14 | 691 | 81 | 115 | 0 |
| 31 Mar 14 | 660 | 78 | 111 | 0 |
| 31 Dec 13 | 633 | 75 | 104 | 0 |
| 30 Sep 13 | 591 | 71 | 97 | 0 |
| 30 Jun 13 | 560 | 68 | 91 | 0 |
Quality Earnings: 300225 has a large one-off gain of CN¥6.2M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 300225 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300225's earnings have declined by 35.9% per year over the past 5 years.
Accelerating Growth: 300225 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 300225 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.4%).
Return on Equity
High ROE: 300225's Return on Equity (2.4%) is considered low.